Genmab A/S (GMAB) reported a profit for first quarter that Dropped, from the same period last year
The company's bottom line came in at $53 million, or $0.83 per share. This compares with $195 million, or $3.05 per share, last year.
The company's revenue for the period rose 25.3% to $896 million from $715 million last year.
Genmab A/S earnings at a glance (GAAP) :
-Earnings: $53 Mln. vs. $195 Mln. last year.-EPS: $0.83 vs. $3.05 last year.-Revenue: $896 Mln vs. $715 Mln last year.
-Guidance:Full year revenue guidance: $ 4.065 B To $ 4.395 B
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.